Efficacy and safety of Panax notoginseng saponins (Xuesaitong) for patients with acute ischemic stroke: a systematic review and meta-analysis of randomized controlled trials.

MLA

Xinyi Shi, et al. “Efficacy and Safety of Panax Notoginseng Saponins (Xuesaitong) for Patients with Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Frontiers in Pharmacology, Oct. 2023, pp. 1–17. EBSCOhost, https://doi.org/10.3389/fphar.2023.1280559.

APA

Xinyi Shi, Luda Feng, Yixuan Li, Mingzhen Qin, Tingting Li, Zixin Cheng, Xuebin Zhang, Congren Zhou, Sisong Cheng, Chi Zhang, & Ying Gao. (2023). Efficacy and safety of Panax notoginseng saponins (Xuesaitong) for patients with acute ischemic stroke: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Pharmacology, 1–17. https://doi.org/10.3389/fphar.2023.1280559

Chicago

Xinyi Shi, Luda Feng, Yixuan Li, Mingzhen Qin, Tingting Li, Zixin Cheng, Xuebin Zhang, et al. 2023. “Efficacy and Safety of Panax Notoginseng Saponins (Xuesaitong) for Patients with Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Frontiers in Pharmacology, October, 1–17. doi:10.3389/fphar.2023.1280559.